Delivery Order SPE2DB22D2206-SPE2DB24FKB23
Award Date
8/29/24
Potential Completion Date
9/20/24
Potential Value
$60K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,323.84, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award, valued at $29,780.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, which has a firm fixed price of $35,736.42, is a delivery order with an ultimate completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has a ceiling value of $3,479.73 and is a Firm Fixed Price Delivery Order with a period of performance through June 20, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,824.28, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. This is a firm-fixed-price delivery order contract with a completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The $23,824.28 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,293.34, is a Delivery Order for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The award has an ultimate completion date of December 20, 2024 and is structured as a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $24,739.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566752320 vials of the drug TIVDAK 40 MG. It is a firm fixed-price delivery order contract with a completion date of January 8, 2025. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...